• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.33 número1

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.33 número1"

Copied!
1
0
0

Texto

(1)

Rev Bras Hematol Hemoter. 2011;33(1) 3

The AIBE and the new phase of the RBHH

Ângelo Maiolino The Associação Ítalo-Brasileira de Hematologia (Italian-Brazilian Association of Hematology – AIBE) was founded on 04/02/2004 in the city of Genoa, Italy. The primary objectives of the AIBE are to promote the integration of the hematology service of both countries through an exchange of healthcare professionals and the development of research of common interest.

Since its inception, the AIBE chose the Revista Brasileira de Hematologia e Hemoterapia (RBHH) as its official vehicle for the publication of scientific articles. For us, it is a great pleasure to participate in this new phase of the journal, its internationalization. The AIBE can be a powerful tool in this process, as publishing the journal in English and its future indexing by Pubmed will increase, without any doubt whatsoever, the interest of colleagues and Italian researchers in publishing their articles in the journal. It is important to note that at present Italy is ranked second in the world in the number of scientific publications in the field of hematology. The Italian members, who helped found the AIBE are also in the leadership and participate in several cooperative groups that develop highly important research protocols. Today, cooperation and multicenter studies are of fundamental importance in the development of medical science and Italy has a long tradition and has advanced greatly in recent years in the development of these studies.

The AIBE and the RBHH are partners in this process and we believe that there will be a great synergy in actions that undoubtedly will lead to great steps forward for both.

Submitted: 2/14/2011 Accepted: 2/14/2011

Correspondence: Ângelo Maiolino Hospital Universitário Clementino Fraga Filho

Rua Professor Rodolpho Paulo Rocco, 255 Serviço de Hematologia, 4º andar, sala 4A12 Cidade Universitária, Ilha do Fundão 21941-913 – Rio de Janeiro (RJ), Brazil Phone: 55 21 - 25622462

Mobile: 55 21-81116663 [email protected]

www.rbhh.org or www.scielo.br/rbhh DOI: 10.5581/1516-8484.20110003

A new era, a new journal

Recently we completed 30 years of hematopoietic stem cell transplantation in Brazil. We have over 50 transplant centers, totaling approximately 320 beds and more than 20,000 transplants have been performed. We have the third largest bone marrow donor registry in the world, with around two million donors registered.

Over the years, the 'Boletim da Sociedade Brasileira de Hematologia e Hemoterapia', which began in 1973, has accompanied all these changes. It became a journal with scientific articles in 1984 (ISSN) and changed in 1999 to 'Revista Brasileira de Hematologia e Hemoterapia' (RBHH). In 2000 the journal was indexed by SciELO, in 2008 by Scopus and now in 2011 we will have the first issue published in English, thus improving international visibility of our Brazilian works.

Moreover, this is the official publication of the Brazilian Society of Bone Marrow Transplantation, where many transplant groups have published their clinical and laboratory studies.

We are very fortunate that Professor Milton Artur Ruiz set his body and mind during long years of his life improving this journal to where today we are proud to publish works related to our area.

It was not without help that the journal has evolved because many other doctors have helped by sending their articles, giving suggestions and supporting the RBHH.

The RBHH, in 2010, edited a special issue in which the Brazilian guidelines for hematopoietic stem cell transplantation were published. This important publication counted on the participation of all transplant centers across the country.

Finally, I would like to congratulate the President of the Associação Brasileira de Hematologia e Hemoterapia, Professor Cármino Antonio de Souza, who with his friendship and understanding always encouraged the development of the RBHH. The Sociedade Brasileira de Transplante de Medula Óssea fully supports the initiative to internationalize the journal with the objective of promoting and improving Brazilian transfusion medicine.

Congratulations to all! Frederico Luiz Dulley

Submitted: 2/14/2011 Accepted: 2/15/2011

Correspondence: Frederico Luiz Dulley

Departamento de Clínica Médica da Faculdade de Medicina da Universidade de São Paulo – USP

Av. Dr. Enéas Carvalho de Aguiar, 155 05403-900 – São Paulo (SP), Brazil Phone: 55 11 3061 5544 [email protected]

www.rbhh.org or www.scielo.br/rbhh DOI: 10.5581/1516-8484.20110002

Editorials

Departamento de Clínica Médica, Faculdade de Medicina,

Universidade de São Paulo – USP São Paulo (SP), Brazil

President, Sociedade Brasileira de Transplante de Medula Óssea

Departamento de Clínica Médica, Universidade Federal do Rio de Janeiro – UFRJ, Rio de Janeiro (RJ) Brazil

President, Associazione Italo-Brasiliana Di Ematologia

Referências

Documentos relacionados

Conclusion: Autologous hematopoietic stem cell transplantation is an effective treatment strategy for early and late relapse in classical Hodgkin's lymphoma for cases that

Methods: A questionnaire was mailed to 36 Brazilian transplant centers with questions about basic oral care protocols, the indication of specific mouthwashes, antibiotic

The aim of the present study was to evaluate allele polymorphisms of the Rh, Kell, Duffy and Kidd blood group systems in a population from the northwestern region of the State

Conclusion: The baseline blood lactate of SS and SC individuals is 3 to 4 times higher than that of healthy subjects, probably due to the fact that these patients have a

Figure 1 – Treatment of MDS, with the probabilities, percentage of response, treatment used and total cost for all patients for each pathway over one year according to this model..

Keywords: Immunophenotyping; Flow cytometry; Paroxysmal nocturnal hemoglobinuria; Diagnosis; Antigen, CD55; Antigen,

of the Revista Brasileira de Hematologia e Hemoterapia was to evaluate hematological and hemostatic abnormalities in patients with the severe form of schistosomiasis and its possible

The article in this issue of the Revista Brasileira de Hematologia e Hemoterapia (RBHH) entitled One window-period donation in two years of individual donor-nucleic acid